BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deng J, Heybati K, Ramaraju HB, Zhou F, Rayner D, Heybati S. Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis. Infection 2022. [PMID: 35438413 DOI: 10.1007/s15010-022-01825-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Garzi G, Cinetto F, Firinu D, Di Napoli G, Lagnese G, Punziano A, Bez P, Cinicola BL, Costanzo G, Scarpa R, Pulvirenti F, Rattazzi M, Spadaro G, Quinti I, Milito C. Real-life data on monoclonal antibodies and antiviral drugs in Italian inborn errors of immunity patients during COVID-19 pandemic. Front Immunol 2022;13:947174. [DOI: 10.3389/fimmu.2022.947174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mencoboni M, Fontana V, Damiani A, Spitaleri A, Raso A, Bottaro LC, Rossi G, Canobbio L, La Camera A, Filiberti RA, Taveggia P, Cavo A. Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy. Current Oncology 2022;29:3364-74. [DOI: 10.3390/curroncol29050273] [Reference Citation Analysis]
3 Redwan EM, Elrashdy F, Aljabali AAA, Baetas-da-cruz W, Barh D, Brufsky AM, Hassan SS, Lundstrom K, Serrano-aroca Á, Takayama K, Tambuwala MM, Uhal BD, Uversky VN. Would New SARS-CoV-2 Variants Change the War against COVID-19? Epidemiologia 2022;3:229-37. [DOI: 10.3390/epidemiologia3020018] [Reference Citation Analysis]